Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?
Ulf AnderssonWilliam OttestadKevin J TraceyPublished in: Molecular medicine (Cambridge, Mass.) (2020)
Based on these observations we propose extracellular HMGB1 to be considered as a therapeutic target for COVID-19.